
LINK . SPRINGER . COM {
}
Title:
Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo | Medical Oncology
Description:
Epithelial ovarian carcinoma is the most lethal of gynecologic malignancies. There is a need to optimize the currently available treatment strategies and to urgently develop novel therapeutic agents against chemotherapy-resistant disease. The objective of our study was to evaluate neratinibās preclinical efficacy in treating HER2-amplified ovarian cancer. Neratinibās efficacy in treating HER2-amplified ovarian cancer was studied in vitro utilizing six primary tumor cell lines with differential HER2/neu expression. Flow cytometry was utilized to assess IC50, cell signaling changes, and cell cycle distribution. Neratinibās in vivo efficacy was evaluated in HER2-amplified epithelial ovarian carcinoma xenografts. Three of six (50%) ovarian cancer cell lines were HER2/neu-amplified. Neratinib showed significantly higher efficacy in treating HER2/neu-amplified cell lines when compared to the non-HER2/neu-amplified tumor cell lines (mean ± SEM IC50:0.010 μM ± 0.0003 vs. 0.076 μM ± 0.005 p < 0.0001). Neratinib treatment significantly decreased the phosphorylation of the transcription factor S6, leading to arrest of the cell cycle in G0/G1 phase. Neratinib prolonged survival in mice harboring HER2-amplified epithelial ovarian carcinoma xenografts (p = 0.003). Neratinib inhibits proliferation, signaling, cell cycle progression and tumor growth of HER2-amplified epithelial ovarian carcinoma in vitro. Neratinib inhibits xenograft growth and improves overall survival in HER2/neu-amplified ovarian cancer in vivo. Clinical trials are warranted.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {š}
- Health & Fitness
- Education
- Science
Content Management System {š}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {š}
What is the average monthly size of link.springer.com audience?
š Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {šø}
We're unsure if the website is profiting.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {š}
cancer, pubmed, article, google, scholar, cas, ovarian, breast, neratinib, carcinoma, treatment, epithelial, cell, central, oncol, bellone, efficacy, herneu, patients, vitro, santin, therapy, trastuzumab, vivo, receptor, serous, gynecol, herpositive, study, phase, growth, clin, res, english, human, uterine, trial, privacy, cookies, content, oncology, herneuamplified, lopez, heramplified, lines, factor, survival, mice, clinical, prognostic,
Topics {āļø}
biomarker triplet nampt/vegf/her2 her2/neu-amplified ovarian cancer month download article/chapter erbb family-targeted agents her2-positive breast cancer hr-/her2+ breast cancer university campus bio-medico differential her2/neu expression trastuzumab-based adjuvant therapy endometrial serous carcinoma u01 ca176067-01a1 grants her2/neu receptor de la garza-salazar ovarian carcinoma tissue her2/neu-amplified epithelial ovarian cancers her2-directed therapy anti-her2 therapy short-term survivors 2-positive breast cancer her2 amplified carcinosarcoma full article pdf metastatic breast cancer recurrent ovarian cancer early breast cancer clinical trials siegel er capecitabine combination therapy human breast cancer privacy choices/manage cookies ovarian carcinoma transcription factor s6 cell cycle progression related subjects c-erbb-2 oncoprotein her2 therapy 2/neu gene amplification g0/g1 phase breast cancer res standard her2 testing nat rev cancer cancer treat rev schwab cl targeted therapies somatic brca1/2 mutations human participants performed article menderes neratinib inhibits proliferation irreversible inhibitor ovarian cancer
Schema {šŗļø}
WebPage:
mainEntity:
headline:Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo
description:Epithelial ovarian carcinoma is the most lethal of gynecologic malignancies. There is a need to optimize the currently available treatment strategies and to urgently develop novel therapeutic agents against chemotherapy-resistant disease. The objective of our study was to evaluate neratinibās preclinical efficacy in treating HER2-amplified ovarian cancer. Neratinibās efficacy in treating HER2-amplified ovarian cancer was studied in vitro utilizing six primary tumor cell lines with differential HER2/neu expression. Flow cytometry was utilized to assess IC50, cell signaling changes, and cell cycle distribution. Neratinibās in vivo efficacy was evaluated in HER2-amplified epithelial ovarian carcinoma xenografts. Three of six (50%) ovarian cancer cell lines were HER2/neu-amplified. Neratinib showed significantly higher efficacy in treating HER2/neu-amplified cell lines when compared to the non-HER2/neu-amplified tumor cell lines (mean ± SEM IC50:0.010 μM ± 0.0003 vs. 0.076 μM ± 0.005 pĀ <Ā 0.0001). Neratinib treatment significantly decreased the phosphorylation of the transcription factor S6, leading to arrest of the cell cycle in G0/G1 phase. Neratinib prolonged survival in mice harboring HER2-amplified epithelial ovarian carcinoma xenografts (pĀ =Ā 0.003). Neratinib inhibits proliferation, signaling, cell cycle progression and tumor growth of HER2-amplified epithelial ovarian carcinoma in vitro. Neratinib inhibits xenograft growth and improves overall survival in HER2/neu-amplified ovarian cancer in vivo. Clinical trials are warranted.
datePublished:2017-04-10T00:00:00Z
dateModified:2017-04-10T00:00:00Z
pageStart:1
pageEnd:8
sameAs:https://doi.org/10.1007/s12032-017-0956-8
keywords:
Neratinib
Epithelial ovarian carcinoma
SCID mice
HER2/neu
Oncology
Hematology
Pathology
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig4_HTML.gif
isPartOf:
name:Medical Oncology
issn:
1559-131X
1357-0560
volumeNumber:34
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Gulden Menderes
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Elena Bonazzoli
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Stefania Bellone
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Jonathan D. Black
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Salvatore Lopez
affiliation:
name:University Campus Bio-Medico of Roma
address:
name:Division of Gynecologic Oncology, University Campus Bio-Medico of Roma, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Francesca Pettinella
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Alice Masserdotti
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Luca Zammataro
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Babak Litkouhi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Elena Ratner
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Dan-Arin Silasi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Masoud Azodi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Peter E. Schwartz
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Alessandro D. Santin
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo
description:Epithelial ovarian carcinoma is the most lethal of gynecologic malignancies. There is a need to optimize the currently available treatment strategies and to urgently develop novel therapeutic agents against chemotherapy-resistant disease. The objective of our study was to evaluate neratinibās preclinical efficacy in treating HER2-amplified ovarian cancer. Neratinibās efficacy in treating HER2-amplified ovarian cancer was studied in vitro utilizing six primary tumor cell lines with differential HER2/neu expression. Flow cytometry was utilized to assess IC50, cell signaling changes, and cell cycle distribution. Neratinibās in vivo efficacy was evaluated in HER2-amplified epithelial ovarian carcinoma xenografts. Three of six (50%) ovarian cancer cell lines were HER2/neu-amplified. Neratinib showed significantly higher efficacy in treating HER2/neu-amplified cell lines when compared to the non-HER2/neu-amplified tumor cell lines (mean ± SEM IC50:0.010 μM ± 0.0003 vs. 0.076 μM ± 0.005 pĀ <Ā 0.0001). Neratinib treatment significantly decreased the phosphorylation of the transcription factor S6, leading to arrest of the cell cycle in G0/G1 phase. Neratinib prolonged survival in mice harboring HER2-amplified epithelial ovarian carcinoma xenografts (pĀ =Ā 0.003). Neratinib inhibits proliferation, signaling, cell cycle progression and tumor growth of HER2-amplified epithelial ovarian carcinoma in vitro. Neratinib inhibits xenograft growth and improves overall survival in HER2/neu-amplified ovarian cancer in vivo. Clinical trials are warranted.
datePublished:2017-04-10T00:00:00Z
dateModified:2017-04-10T00:00:00Z
pageStart:1
pageEnd:8
sameAs:https://doi.org/10.1007/s12032-017-0956-8
keywords:
Neratinib
Epithelial ovarian carcinoma
SCID mice
HER2/neu
Oncology
Hematology
Pathology
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12032-017-0956-8/MediaObjects/12032_2017_956_Fig4_HTML.gif
isPartOf:
name:Medical Oncology
issn:
1559-131X
1357-0560
volumeNumber:34
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Gulden Menderes
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Elena Bonazzoli
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Stefania Bellone
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Jonathan D. Black
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Salvatore Lopez
affiliation:
name:University Campus Bio-Medico of Roma
address:
name:Division of Gynecologic Oncology, University Campus Bio-Medico of Roma, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:Francesca Pettinella
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Alice Masserdotti
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Luca Zammataro
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Babak Litkouhi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Elena Ratner
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Dan-Arin Silasi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Masoud Azodi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Peter E. Schwartz
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:Alessandro D. Santin
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Medical Oncology
issn:
1559-131X
1357-0560
volumeNumber:34
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:University Campus Bio-Medico of Roma
address:
name:Division of Gynecologic Oncology, University Campus Bio-Medico of Roma, Rome, Italy
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Gulden Menderes
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Elena Bonazzoli
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Stefania Bellone
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Jonathan D. Black
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Salvatore Lopez
affiliation:
name:University Campus Bio-Medico of Roma
address:
name:Division of Gynecologic Oncology, University Campus Bio-Medico of Roma, Rome, Italy
type:PostalAddress
type:Organization
name:Francesca Pettinella
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Alice Masserdotti
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Luca Zammataro
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Babak Litkouhi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Elena Ratner
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Dan-Arin Silasi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Masoud Azodi
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Peter E. Schwartz
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
name:Alessandro D. Santin
affiliation:
name:Yale University School of Medicine
address:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Division of Gynecologic Oncology, University Campus Bio-Medico of Roma, Rome, Italy
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
name:Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {š}(220)
- How much does https://www.springernature.com/gp/authors bring in each month?
- What's the profit of https://link.springernature.com/home/?
- What's the financial outcome of https://order.springer.com/public/cart?
- How much profit does https://submission.springernature.com/new-submission/12032/3 generate?
- Monthly income for https://www.springernature.com/gp/librarians/licensing/agc/journals
- https://doi.org/10.3322/caac.21332's financial summary
- Financial intake of https://doi.org/10.3322%2Fcaac.21332
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26742998 bring in each month?
- See how much http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202016&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.21332&volume=66&issue=1&pages=7-30&publication_year=2016&author=Siegel%2CRL&author=Miller%2CKD&author=Jemal%2CA makes per month
- How much income is https://doi.org/10.1038/nrc2583 earning monthly?
- How much cash flow does https://doi.org/10.1038%2Fnrc2583 have monthly?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19238149
- How much does http://scholar.google.com/scholar_lookup?&title=Beyond%20chemotherapy%3A%20targeted%20therapies%20in%20ovarian%20cancer&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2583&volume=9&issue=3&pages=167-181&publication_year=2009&author=Yap%2CTA&author=Carden%2CCP&author=Kaye%2CSB gross monthly?
- How much revenue does https://doi.org/10.1158/1078-0432.ccr-12-2243 bring in?
- What's the monthly money flow for https://doi.org/10.1158%2F1078-0432.CCR-12-2243?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23307860 rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=New%20strategies%20in%20the%20treatment%20of%20ovarian%20cancer%3A%20current%20clinical%20perspectives%20and%20future%20potential&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.ccr-12-2243&volume=19&issue=5&pages=961-968&publication_year=2013&author=Banerjee%2CS&author=Kaye%2CSB gross monthly?
- How much profit is https://doi.org/10.1097/igc.0000000000000721 making per month?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27177282?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=An%20integrative%20genomic%20analysis%20of%20formalin%20fixed%20paraffin-embedded%20archived%20serous%20ovarian%20carcinoma%20comparing%20long-term%20and%20short-term%20survivors&journal=Int%20J%20Gynecol%20Cancer&doi=10.1097%2Figc.0000000000000721&publication_year=2016&author=Stalberg%2CK&author=Crona%2CJ&author=Razmara%2CM&author=Taslica%2CD&author=Skogseid%2CB&author=Stalberg%2CP
- What's the monthly income of https://doi.org/10.1002/cam4.748?
- http://scholar.google.com/scholar_lookup?&title=Detection%20of%20somatic%20BRCA1%2F2%20mutations%20in%20ovarian%20cancer%E2%80%94next-generation%20sequencing%20analysis%20of%20100%20cases&journal=Cancer%20Med&doi=10.1002%2Fcam4.748&publication_year=2016&author=Magdalena%2CK&author=Monika%2CZ&author=Adam%2CG&author=Magdalena%2CR&author=Marzena%2CL&author=Wojciech%2CB's financial summary
- What's the profit of https://doi.org/10.1016/j.ctrv.2013.10.002?
- How much does https://doi.org/10.1016%2Fj.ctrv.2013.10.002 generate monthly?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24216225's earnings
- How much money does http://scholar.google.com/scholar_lookup?&title=Current%20challenges%20and%20clinical%20investigations%20of%20epidermal%20growth%20factor%20receptor%20%28EGFR%29-%20and%20ErbB%20family-targeted%20agents%20in%20the%20treatment%20of%20head%20and%20neck%20squamous%20cell%20carcinoma%20%28HNSCC%29&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2013.10.002&volume=40&issue=4&pages=567-577&publication_year=2014&author=Cohen%2CRB generate?
- What's the revenue for https://doi.org/10.1007/s40291-013-0024-9?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23529353?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660991 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=HER2%20expression%20beyond%20breast%20cancer%3A%20therapeutic%20implications%20for%20gynecologic%20malignancies&journal=Mol%20Diagn%20Ther&doi=10.1007%2Fs40291-013-0024-9&volume=17&issue=2&pages=85-99&publication_year=2013&author=English%2CDP&author=Roque%2CDM&author=Santin%2CAD rake in every month?
- How much revenue does https://doi.org/10.1371/journal.pone.0001138 generate?
- How much revenue does https://doi.org/10.1371%2Fjournal.pone.0001138 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17987122 income
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042515 pull in monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=HER2%20status%20in%20ovarian%20carcinomas%3A%20a%20multicenter%20GINECO%20study%20of%20320%20patients&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0001138&volume=2&issue=11&publication_year=2007&author=Tuefferd%2CM&author=Couturier%2CJ&author=Penault-Llorca%2CF&author=Vincent-Salomon%2CA&author=Broet%2CP&author=Guastalla%2CJP
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2564806
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20c-erbB-2%20oncoprotein%3A%20a%20prognostic%20indicator%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=49&issue=8&pages=2087-2090&publication_year=1989&author=Wright%2CC&author=Angus%2CB&author=Nicholson%2CS&author=Sainsbury%2CJR&author=Cairns%2CJ&author=Gullick%2CWJ bring in each month?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1972347 generate?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20HER-2%2Fneu%20is%20associated%20with%20poor%20survival%20in%20advanced%20epithelial%20ovarian%20cancer&journal=Cancer%20Res&volume=50&issue=13&pages=4087-4091&publication_year=1990&author=Berchuck%2CA&author=Kamel%2CA&author=Whitaker%2CR&author=Kerns%2CB&author=Olt%2CG&author=Kinney%2CR each month?
- Discover the revenue of https://doi.org/10.1016/j.ajog.2004.10.605
- https://doi.org/10.1016%2Fj.ajog.2004.10.605's financial summary
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15746676?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Racial%20differences%20in%20the%20overexpression%20of%20epidermal%20growth%20factor%20type%20II%20receptor%20%28HER2%2Fneu%29%3A%20a%20major%20prognostic%20indicator%20in%20uterine%20serous%20papillary%20cancer&journal=Am%20J%20Obstet%20Gynecol&doi=10.1016%2Fj.ajog.2004.10.605&volume=192&issue=3&pages=813-818&publication_year=2005&author=Santin%2CAD&author=Bellone%2CS&author=Siegel%2CER&author=Palmieri%2CM&author=Thomas%2CM&author=Cannon%2CMJ?
- How much does https://doi.org/10.1016/j.ygyno.2014.08.006 pull in monthly?
- How much does https://doi.org/10.1016%2Fj.ygyno.2014.08.006 pull in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25124161 make?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Neratinib%20shows%20efficacy%20in%20the%20treatment%20of%20HER2%2Fneu%20amplified%20uterine%20serous%20carcinoma%20in%20vitro%20and%20in%20vivo&journal=Gynecol%20Oncol&doi=10.1016%2Fj.ygyno.2014.08.006&volume=135&issue=1&pages=142-148&publication_year=2014&author=Schwab%2CCL&author=English%2CDP&author=Roque%2CDM&author=Bellone%2CS&author=Lopez%2CS&author=Cocco%2CE
- Get to know https://doi.org/10.1016/j.ajog.2013.07.020's earnings
- Revenue of https://doi.org/10.1016%2Fj.ajog.2013.07.020
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Oncogenic%20PIK3CA%20gene%20mutations%20and%20HER2%2Fneu%20gene%20amplifications%20determine%20the%20sensitivity%20of%20uterine%20serous%20carcinoma%20cell%20lines%20to%20GDC-0980%2C%20a%20selective%20inhibitor%20of%20Class%20I%20PI3%20kinase%20and%20mTOR%20kinase%20%28TORC1%2F2%29&journal=Am%20J%20Obstet%20Gynecol&doi=10.1016%2Fj.ajog.2013.07.020&volume=209&issue=5&pages=465.e1-465.e9&publication_year=2013&author=English%2CDP&author=Bellone%2CS&author=Cocco%2CE&author=Bortolomai%2CI&author=Pecorelli%2CS&author=Lopez%2CS each month?
- What's https://doi.org/10.1038/sj.bjc.6605448's gross income?
- How profitable is https://doi.org/10.1038%2Fsj.bjc.6605448?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19920829 making per month?
- http://scholar.google.com/scholar_lookup?&title=In%20vitro%20activity%20of%20pertuzumab%20in%20combination%20with%20trastuzumab%20in%20uterine%20serous%20papillary%20adenocarcinoma&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6605448&volume=102&issue=1&pages=134-143&publication_year=2010&author=El-Sahwi%2CK&author=Bellone%2CS&author=Cocco%2CE&author=Cargnelutti%2CM&author=Casagrande%2CF&author=Bellone%2CM's financial summary
- How much profit does https://doi.org/10.1016/j.ygyno.2015.08.002 generate?
- Earnings of https://doi.org/10.1016%2Fj.ygyno.2015.08.002
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26260909?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587290 generate?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Neratinib%20shows%20efficacy%20in%20the%20treatment%20of%20HER2%20amplified%20carcinosarcoma%20in%20vitro%20and%20in%20vivo&journal=Gynecol%20Oncol&doi=10.1016%2Fj.ygyno.2015.08.002&volume=139&issue=1&pages=112-117&publication_year=2015&author=Schwab%2CCL&author=English%2CDP&author=Black%2CJ&author=Bellone%2CS&author=Lopez%2CS&author=Cocco%2CE make?
- Profit of https://doi.org/10.1038/modpathol.2013.113
- What's the monthly income of https://doi.org/10.1038%2Fmodpathol.2013.113?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23765245
- How much does http://scholar.google.com/scholar_lookup?&title=Toward%20standard%20HER2%20testing%20of%20endometrial%20serous%20carcinoma%3A%204-year%20experience%20at%20a%20large%20academic%20center%20and%20recommendations%20for%20clinical%20practice&journal=Mod%20Pathol&doi=10.1038%2Fmodpathol.2013.113&volume=26&issue=12&pages=1605-1612&publication_year=2013&author=Buza%2CN&author=English%2CDP&author=Santin%2CAD&author=Hui%2CP net monthly?
- What's the income of https://doi.org/10.1002/cam4.274?
- Check the income stats for https://doi.org/10.1002%2Fcam4.274
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24890382 rake in every month?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302675 have monthly?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=T-DM1%2C%20a%20novel%20antibody-drug%20conjugate%2C%20is%20highly%20effective%20against%20primary%20HER2%20overexpressing%20uterine%20serous%20carcinoma%20in%20vitro%20and%20in%20vivo&journal=Cancer%20Med&doi=10.1002%2Fcam4.274&volume=3&issue=5&pages=1256-1265&publication_year=2014&author=English%2CDP&author=Bellone%2CS&author=Schwab%2CCL&author=Bortolomai%2CI&author=Bonazzoli%2CE&author=Cocco%2CE have monthly?
- What is the monthly revenue of https://doi.org/10.1158/0008-5472.can-03-2868?
- Profit of https://doi.org/10.1158%2F0008-5472.CAN-03-2868
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15173008's revenue stream
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Antitumor%20activity%20of%20HKI-272%2C%20an%20orally%20active%2C%20irreversible%20inhibitor%20of%20the%20HER-2%20tyrosine%20kinase&journal=Cancer%20Res&doi=10.1158%2F0008-5472.can-03-2868&volume=64&issue=11&pages=3958-3965&publication_year=2004&author=Rabindran%2CSK&author=Discafani%2CCM&author=Rosfjord%2CEC&author=Baxter%2CM&author=Floyd%2CMB&author=Golas%2CJ
- What's the income generated by https://doi.org/10.1016/j.ctrv.2012.05.004 each month?
- What's https://doi.org/10.1016%2Fj.ctrv.2012.05.004's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22703833 pull in monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=The%20evolving%20landscape%20of%20protein%20kinases%20in%20breast%20cancer%3A%20clinical%20implications&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2012.05.004&volume=39&issue=1&pages=68-76&publication_year=2013&author=Ocana%2CA&author=Amir%2CE&author=Seruga%2CB&author=Martin%2CM&author=Pandiella%2CA make?
- How much does https://doi.org/10.2165%2F00003495-200767090-00006 generate monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17547474 make?
- http://scholar.google.com/scholar_lookup?&title=HER2-positive%20breast%20cancer%3A%20current%20and%20future%20treatment%20strategies&journal=Drugs&doi=10.2165%2F00003495-200767090-00006&volume=67&issue=9&pages=1329-1341&publication_year=2007&author=Engel%2CRH&author=Kaklamani%2CVG's revenue stream
- What's the income of https://doi.org/10.2165%2F00063030-200721020-00001?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17402790
- Financial intake of http://scholar.google.com/scholar_lookup?&title=HER-2-positive%20breast%20cancer%3A%20hope%20beyond%20trastuzumab&journal=BioDrugs&doi=10.2165%2F00063030-200721020-00001&volume=21&issue=2&pages=69-77&publication_year=2007&author=Bartsch%2CR&author=Wenzel%2CC&author=Zielinski%2CCC&author=Steger%2CGG
- https://doi.org/10.3892/or.2015.4391's financial summary
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26531769 produce monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Biomarker%20triplet%20NAMPT%2FVEGF%2FHER2%20as%20a%20de%20novo%20detection%20panel%20for%20the%20diagnosis%20and%20prognosis%20of%20human%20breast%20cancer&journal=Oncol%20Rep&doi=10.3892%2For.2015.4391&volume=35&issue=1&pages=454-462&publication_year=2016&author=Zhu%2CY&author=Guo%2CM&author=Zhang%2CL&author=Xu%2CT&author=Wang%2CL&author=Xu%2CG
- Get to know what's the income of https://doi.org/10.1016/j.lungcan.2014.12.018
- Get to know what's the income of https://doi.org/10.1016%2Fj.lungcan.2014.12.018
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25601485 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20HER2%20in%20the%20treatment%20of%20non-small%20cell%20lung%20cancer&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2014.12.018&volume=87&issue=3&pages=220-225&publication_year=2015&author=Mar%2CN&author=Vredenburgh%2CJJ&author=Wasser%2CJS rake in every month?
- How much income does https://doi.org/10.1016/j.ctrv.2006.01.001 have?
- What's the monthly money flow for https://doi.org/10.1016%2Fj.ctrv.2006.01.001?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16483720's total income per month
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Prognostic%2C%20predictive%20and%20therapeutic%20implications%20of%20HER2%20in%20invasive%20epithelial%20ovarian%20cancer&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2006.01.001&volume=32&issue=3&pages=180-190&publication_year=2006&author=Serrano-Olvera%2CA&author=Duenas-Gonzalez%2CA&author=Gallardo-Rincon%2CD&author=Candelaria%2CM&author=Garza-Salazar%2CJ?
- How much cash flow does https://doi.org/10.1002/cncr.11476 have monthly?
- What's the financial gain of https://doi.org/10.1002%2Fcncr.11476?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12833457 produce monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=Distribution%20of%20HER-2%20overexpression%20in%20ovarian%20carcinoma%20tissue%20and%20its%20prognostic%20value%20in%20patients%20with%20ovarian%20carcinoma%3A%20from%20the%20Danish%20MALOVA%20Ovarian%20Cancer%20Study&journal=Cancer&doi=10.1002%2Fcncr.11476&volume=98&issue=1&pages=66-73&publication_year=2003&author=Hogdall%2CEV&author=Christensen%2CL&author=Kjaer%2CSK&author=Blaakaer%2CJ&author=Bock%2CJE&author=Glud%2CE have?
- How much profit is https://doi.org/10.1126%2Fscience.3798106 making per month?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3798106 making per month?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Human%20breast%20cancer%3A%20correlation%20of%20relapse%20and%20survival%20with%20amplification%20of%20the%20HER-2%2Fneu%20oncogene&journal=Science&doi=10.1126%2Fscience.3798106&volume=235&issue=4785&pages=177-182&publication_year=1987&author=Slamon%2CDJ&author=Clark%2CGM&author=Wong%2CSG&author=Levin%2CWJ&author=Ullrich%2CA&author=McGuire%2CWL?
- Earnings of https://doi.org/10.1200/jco.2005.11.890
- What's https://doi.org/10.1200%2FJCO.2005.11.890's gross income?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15753456's total income per month
- http://scholar.google.com/scholar_lookup?&title=Critical%20update%20and%20emerging%20trends%20in%20epidermal%20growth%20factor%20receptor%20targeting%20in%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2005.11.890&volume=23&issue=11&pages=2445-2459&publication_year=2005&author=Baselga%2CJ&author=Arteaga%2CCL's financial summary
- Profit of https://doi.org/10.1200/jco.2014.55.5730
- How much does https://doi.org/10.1200%2FJCO.2014.55.5730 generate monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25332249
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226805's financial summary
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Trastuzumab%20plus%20adjuvant%20chemotherapy%20for%20human%20epidermal%20growth%20factor%20receptor%202-positive%20breast%20cancer%3A%20planned%20joint%20analysis%20of%20overall%20survival%20from%20NSABP%20B-31%20and%20NCCTG%20N9831&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2014.55.5730&volume=32&issue=33&pages=3744-3752&publication_year=2014&author=Perez%2CEA&author=Romond%2CEH&author=Suman%2CVJ&author=Jeong%2CJH&author=Sledge%2CG&author=Geyer%2CCE?
- Monthly income for https://doi.org/10.1016/s1470-2045(11)70033-x
- Earnings of https://doi.org/10.1016%2FS1470-2045%2811%2970033-X
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21354370?
- How much money does http://scholar.google.com/scholar_lookup?&title=Treatment%20with%20trastuzumab%20for%201%C2%A0year%20after%20adjuvant%20chemotherapy%20in%20patients%20with%20HER2-positive%20early%20breast%20cancer%3A%20a%204-year%20follow-up%20of%20a%20randomised%20controlled%20trial&journal=Lancet%20Oncol&doi=10.1016%2Fs1470-2045%2811%2970033-x&volume=12&issue=3&pages=236-244&publication_year=2011&author=Gianni%2CL&author=Dafni%2CU&author=Gelber%2CRD&author=Azambuja%2CE&author=Muehlbauer%2CS&author=Goldhirsch%2CA make?
- How much does https://doi.org/10.1056/NEJMoa0910383 bring in each month?
- What's the profit of https://doi.org/10.1056%2FNEJMoa0910383?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21991949 generate?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268553
- How much does http://scholar.google.com/scholar_lookup?&title=Adjuvant%20trastuzumab%20in%20HER2-positive%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0910383&volume=365&issue=14&pages=1273-1283&publication_year=2011&author=Slamon%2CD&author=Eiermann%2CW&author=Robert%2CN&author=Pienkowski%2CT&author=Martin%2CM&author=Press%2CM make?
- What's the financial gain of https://doi.org/10.1016/s1470-2045(15)00551-3?
- https://doi.org/10.1016%2FS1470-2045%2815%2900551-3's financial summary
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26874901 make?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Neratinib%20after%20trastuzumab-based%20adjuvant%20therapy%20in%20patients%20with%20HER2-positive%20breast%20cancer%20%28ExteNET%29%3A%20a%20multicentre%2C%20randomised%2C%20double-blind%2C%20placebo-controlled%2C%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2Fs1470-2045%2815%2900551-3&volume=17&issue=3&pages=367-377&publication_year=2016&author=Chan%2CA&author=Delaloge%2CS&author=Holmes%2CFA&author=Moy%2CB&author=Iwata%2CH&author=Harvey%2CVJ
- What's https://doi.org/10.1016/s0140-6736(13)61094-6's gross income?
- Revenue of https://doi.org/10.1016%2FS0140-6736%2813%2961094-6
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23871490 have?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=2%C2%A0years%20versus%201%C2%A0year%20of%20adjuvant%20trastuzumab%20for%20HER2-positive%20breast%20cancer%20%28HERA%29%3A%20an%20open-label%2C%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2Fs0140-6736%2813%2961094-6&volume=382&issue=9897&pages=1021-1028&publication_year=2013&author=Goldhirsch%2CA&author=Gelber%2CRD&author=Piccart-Gebhart%2CMJ&author=Azambuja%2CE&author=Procter%2CM&author=Suter%2CTM
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23687784 rake in every month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=HER2-directed%20therapy%20for%20metastatic%20breast%20cancer&journal=Oncology&volume=27&issue=3&pages=166-175&publication_year=2013&author=Jelovac%2CD&author=Emens%2CLA
- What's the income of https://doi.org/10.1097/IGC.0b013e31826d1438?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23027040?
- What's http://scholar.google.com/scholar_lookup?&title=Expected%20benefits%20of%20topotecan%20combined%20with%20lapatinib%20in%20recurrent%20ovarian%20cancer%20according%20to%20biological%20profile%3A%20a%20phase%202%20trial&journal=Int%20J%20Gynecol%20Cancer&doi=10.1097%2FIGC.0b013e31826d1438&volume=22&issue=9&pages=1483-1488&publication_year=2012&author=Lheureux%2CS&author=Krieger%2CS&author=Weber%2CB&author=Pautier%2CP&author=Fabbro%2CM&author=Selle%2CF's gross income?
- How much does https://doi.org/10.1016/j.ygyno.2014.09.003 pull in?
- How much does https://doi.org/10.1016%2Fj.ygyno.2014.09.003 generate monthly?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25220628 making per month?
- See how much http://scholar.google.com/scholar_lookup?&title=Targeting%20HER2%20in%20ovarian%20and%20uterine%20cancers%3A%20challenges%20and%20future%20directions&journal=Gynecol%20Oncol&doi=10.1016%2Fj.ygyno.2014.09.003&volume=135&issue=2&pages=364-370&publication_year=2014&author=Teplinsky%2CE&author=Muggia%2CF makes per month
- Learn how profitable https://doi.org/10.1038/bjc.2013.178 is on a monthly basis
- https://doi.org/10.1038%2Fbjc.2013.178 income
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23632474?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670493?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Combination%20neratinib%20%28HKI-272%29%20and%20paclitaxel%20therapy%20in%20patients%20with%20HER2-positive%20metastatic%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2013.178&volume=108&issue=10&pages=1985-1993&publication_year=2013&author=Chow%2CLW&author=Xu%2CB&author=Gupta%2CS&author=Freyman%2CA&author=Zhao%2CY&author=Abbas%2CR
- https://doi.org/10.1158/1078-0432.ccr-08-1978's financial summary
- What's the financial outcome of https://doi.org/10.1158%2F1078-0432.CCR-08-1978?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19318484 bring in each month?
- How profitable is http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20with%20neratinib%20%28HKI-272%29%2C%20an%20irreversible%20pan%20ErbB%20receptor%20tyrosine%20kinase%20inhibitor%2C%20in%20patients%20with%20solid%20tumors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.ccr-08-1978&volume=15&issue=7&pages=2552-2558&publication_year=2009&author=Wong%2CKK&author=Fracasso%2CPM&author=Bukowski%2CRM&author=Lynch%2CTJ&author=Munster%2CPN&author=Shapiro%2CGI?
- What's the monthly income of https://doi.org/10.1200/jco.2009.25.8707?
- How much profit is https://doi.org/10.1200%2FJCO.2009.25.8707 making per month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20142587 pull in?
- How much income is http://scholar.google.com/scholar_lookup?&title=Neratinib%2C%20an%20irreversible%20ErbB%20receptor%20tyrosine%20kinase%20inhibitor%2C%20in%20patients%20with%20advanced%20ErbB2-positive%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2009.25.8707&volume=28&issue=8&pages=1301-1307&publication_year=2010&author=Burstein%2CHJ&author=Sun%2CY&author=Dirix%2CLY&author=Jiang%2CZ&author=Paridaens%2CR&author=Tan%2CAR earning monthly?
- How much profit does https://doi.org/10.1186/bcr1612 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17096862 earn?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797036
- How much does http://scholar.google.com/scholar_lookup?&title=HER2%20therapy%3A%20molecular%20mechanisms%20of%20trastuzumab%20resistance&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr1612&volume=8&issue=6&publication_year=2006&author=Nahta%2CR&author=Esteva%2CFJ make?
- https://doi.org/10.1016/j.ejca.2013.07.142 income
- Get to know what's the income of https://doi.org/10.1016%2Fj.ejca.2013.07.142
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23953056 make?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20phase%20two%20randomised%20trial%20of%20neratinib%20monotherapy%20versus%20lapatinib%20plus%20capecitabine%20combination%20therapy%20in%20patients%20with%20HER2%2B%20advanced%20breast%20cancer&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2013.07.142&volume=49&issue=18&pages=3763-3772&publication_year=2013&author=Martin%2CM&author=Bonneterre%2CJ&author=Geyer%2CCE&author=Ito%2CY&author=Ro%2CJ&author=Lang%2CI pull in?
- https://doi.org/10.1097%2F01.COT.0000450342.03865.8f's financial summary
- Revenue of http://scholar.google.com/scholar_lookup?&title=I-SPY%202%20trial%3A%20neoadjuvant%20neratinib%20improves%20pathologic%20complete%20response%20in%20HR-%2FHER2%2B%20breast%20cancer&journal=Oncology%20Times&doi=10.1097%2F01.COT.0000450342.03865.8f&volume=36&issue=10&pages=25-26&publication_year=2014&author=Carlson%2CR
- How much profit does https://doi.org/10.1056/NEJMoa1513750 make?
- What's the revenue for https://doi.org/10.1056%2FNEJMoa1513750?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27406346's total income per month
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259558 produce monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Adaptive%20randomization%20of%20neratinib%20in%20early%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1513750&volume=375&issue=1&pages=11-22&publication_year=2016&author=Park%2CJW&author=Liu%2CMC&author=Yee%2CD&author=Yau%2CC&author=van%20%E2%80%98t%20Veer%2CLJ&author=Symmans%2CWF?
- What's the monthly money flow for https://doi.org/10.18632/oncotarget.1148?
- How much does https://doi.org/10.18632%2Foncotarget.1148 gross monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24009064?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858548?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Neratinib%20overcomes%20trastuzumab%20resistance%20in%20HER2%20amplified%20breast%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.1148&volume=4&issue=10&pages=1592-1605&publication_year=2013&author=Canonici%2CA&author=Gijsen%2CM&author=Mullooly%2CM&author=Bennett%2CR&author=Bouguern%2CN&author=Pedersen%2CK?
- How much does https://doi.org/10.1093/annonc/mds284 gross monthly?
- How much income does https://doi.org/10.1093%2Fannonc%2Fmds284 have?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22967996 bring in each month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Safety%20and%20efficacy%20of%20neratinib%20%28HKI-272%29%20plus%20vinorelbine%20in%20the%20treatment%20of%20patients%20with%20ErbB2-positive%20metastatic%20breast%20cancer%20pretreated%20with%20anti-HER2%20therapy&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmds284&volume=24&issue=1&pages=109-116&publication_year=2013&author=Awada%2CA&author=Dirix%2CL&author=Manso%20Sanchez%2CL&author=Xu%2CB&author=Luu%2CT&author=Dieras%2CV?
- How much income is https://citation-needed.springer.com/v2/references/10.1007/s12032-017-0956-8?format=refman&flavour=references earning monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gulden%20Menderes make?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gulden%20Menderes%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Elena%20Bonazzoli earns monthly
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Elena%20Bonazzoli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stefania%20Bellone
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stefania%20Bellone%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jonathan%20D.%20Black
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jonathan%20D.%20Black%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Salvatore%20Lopez income
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Salvatore%20Lopez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Francesca%20Pettinella
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Francesca%20Pettinella%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alice%20Masserdotti
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alice%20Masserdotti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luca%20Zammataro?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luca%20Zammataro%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Babak%20Litkouhi produce monthly?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Babak%20Litkouhi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Elena%20Ratner?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Elena%20Ratner%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dan-Arin%20Silasi pull in?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dan-Arin%20Silasi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masoud%20Azodi produce monthly?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masoud%20Azodi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20E.%20Schwartz?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20E.%20Schwartz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alessandro%20D.%20Santin make?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alessandro%20D.%20Santin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- Discover the revenue of https://s100.copyright.com/AppDispatchServlet?title=Efficacy%20of%20neratinib%20in%20the%20treatment%20of%20HER2%2Fneu-amplified%20epithelial%20ovarian%20carcinoma%20in%20vitro%20and%20in%20vivo&author=Gulden%20Menderes%20et%20al&contentID=10.1007%2Fs12032-017-0956-8©right=Springer%20Science%2BBusiness%20Media%20New%20York&publication=1357-0560&publicationDate=2017-04-10&publisherName=SpringerNature&orderBeanReset=true
- https://crossmark.crossref.org/dialog/?doi=10.1007/s12032-017-0956-8's financial summary
- See how much https://citation-needed.springer.com/v2/references/10.1007/s12032-017-0956-8?format=refman&flavour=citation makes per month
- What's the financial intake of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- Earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- https://www.springernature.com/gp/products's total income per month
- What's the profit of https://www.springernature.com/gp/librarians?
- What's the profit of https://www.springernature.com/gp/societies?
- What's the income of https://www.springernature.com/gp/partners?
- How much does https://www.springer.com/ gross monthly?
- What's the total monthly financial gain of https://www.nature.com/?
- How much money does https://www.biomedcentral.com/ generate?
- What's the income generated by https://www.palgrave.com/ each month?
- How much does https://www.apress.com/ gross monthly?
- How much does https://www.springernature.com/gp/legal/ccpa rake in every month?
- How much revenue does https://www.springernature.com/gp/info/accessibility produce monthly?
- Explore the financials of https://support.springernature.com/en/support/home
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations net monthly?
- Financial intake of https://www.springernature.com/
Analytics and Tracking {š}
- Google Tag Manager
Libraries {š}
- Clipboard.js
- Prism.js
CDN Services {š¦}
- Crossref